| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 445.49B | 443.50B | 411.65B | 494.64B | 427.16B | 346.12B |
| Gross Profit | 56.57B | 55.61B | 53.68B | 53.59B | 36.76B | 17.43B |
| EBITDA | 46.02B | 46.83B | 44.22B | 44.68B | 30.03B | 11.58B |
| Net Income | 23.59B | 20.81B | 24.72B | 18.37B | 9.87B | -12.07B |
Balance Sheet | ||||||
| Total Assets | 765.84B | 782.13B | 727.00B | 685.79B | 734.50B | 707.80B |
| Cash, Cash Equivalents and Short-Term Investments | 50.51B | 51.32B | 69.62B | 72.80B | 70.83B | 51.38B |
| Total Debt | 357.56B | 366.16B | 316.84B | 334.87B | 347.79B | 345.44B |
| Total Liabilities | 509.82B | 526.08B | 491.16B | 483.91B | 555.41B | 537.85B |
| Stockholders Equity | 247.76B | 249.26B | 229.30B | 195.12B | 173.00B | 164.60B |
Cash Flow | ||||||
| Free Cash Flow | -18.52B | -67.87B | 6.17B | 21.51B | 4.69B | -52.78B |
| Operating Cash Flow | -2.54B | 15.61B | 62.21B | 43.77B | 30.59B | -9.94B |
| Investing Cash Flow | -15.31B | -74.55B | -42.03B | -24.60B | -10.34B | -29.15B |
| Financing Cash Flow | 5.18B | 39.23B | -25.96B | -19.16B | -1.68B | 56.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥352.54B | 9.85 | ― | 1.61% | 6.55% | -12.49% | |
73 Outperform | ¥249.51B | 4.69 | 12.70% | 1.68% | 8.29% | 24.94% | |
65 Neutral | ¥609.91B | 12.46 | 8.51% | 2.96% | -2.82% | -50.73% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥576.94B | 5.46 | 9.94% | 2.49% | 1.72% | 10.19% | |
62 Neutral | ¥44.84B | 14.50 | ― | 2.17% | 4.37% | 54.12% | |
59 Neutral | ¥574.46B | 8.46 | 9.26% | 2.68% | 10.39% | 32.43% |